FINANCE, RISK AND AUDIT COMMITTEE

Assisting the Board of Directors on all aspects of financial and risk management.

Role

The aim of the Finance, Risk and Audit Committee (FRAC) is to monitor the financial solvency of Breast Cancer Trials (BCT), assess the processes BCT uses to properly and efficiently manage its financial responsibilities, review BCT’s risk appetite and risk tolerance and monitor the risks faced and likelihood of occurrence, and assess the internal processes for determining compliance with laws, regulations, standards and best practice guidelines.

Members of FRAC work closely with BCT’s Chief Executive Officer (CEO) and Financial Controller to review the financial structure of the Group, and set the Group’s risk appetite for adoption by the Board, which is reviewed annually.

FRAC’s indicators of performance include, but are not limited to:

Ensuring BCT’s financial position can support current and future committed BCT activities
Ensuring BCT’s financial profile is appropriate and able to support the overall Strategic Plan
Ensuring adherence to BCT’s risk statement
Ensuring compliance with regulations associated with the business

Members of FRAC are:

Mr Luke Bugden, Chair of FRAC and Board Director
Ms Michelle Cairns, BCT Financial Controller and Company Secretary (attendee)
Professor Andrew Spillane, Board Director
Ms Judith Smith, Appointed Member
Adjunct Professor Soozy Smith, Chief Executive Officer

Mr Luke Bugden

Mr Luke Bugden was appointed to the Breast Cancer Trials Board of Directors in October 2019 and is the Chair of the Finance, Risk and Audit Committee.